First human tests begin for potential lung disease pill
NCT ID NCT07493031
Summary
This is a very early study to check if a new tablet called HW252001 is safe for people and to see how the body handles it. It will involve about 98 healthy adults who will take either the tablet or a placebo (a dummy pill). The main goal is to find the right dose and understand any side effects before testing in people with the lung disease IPF.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IPF are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430100, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.